Thermo Fisher Scientific introduces the Nicolet RaptIR X FTIR Microscope, offering optical and infrared analysis for ...

A bipartisan Senate bill would require Medicare contractors to review local coverage requests within 60 days and increase ...

FDA clears Qiagen’s QIAstat-Dx BCID GN Plus AMR Panel, enabling US labs to detect 13 gram-negative pathogens and 18 resistance markers.

An FDA panel voted in favor of GRAIL’s Galleri multi-cancer early detection test, citing benefits outweigh risks for adults ...

A study found ambulance use of point-of-care troponin testing helped one-third of chest pain patients avoid ED transport.

Researchers report a portable test that distinguishes seven mosquito-borne viruses in under an hour, as published in ...

Garvan Institute researchers developed a long-read nanopore DNA assay that detects inherited muscle diseases missed by ...

Lucid Diagnostics receives CMS panel support to maintain EsoGuard Medicare payment, gains new CPT code for EsoCheck, and ...

Castle Biosciences has opened a 55,000-square-foot laboratory in Scottsdale, Ariz, to expand molecular diagnostic testing ...

CMS releases preliminary 2027 CLFS rates showing potential payment reductions for over 1,100 test codes, capped at 15% annually until 2029.

Thermo Fisher launches the Gibco CHO-K1 Catalog Panel, reporting up to 73% higher titer and 202% higher cell density in fed-batch studies.

Werfen’s Aptiva APS IgA Reagent receives FDA clearance and CE mark, completing the company’s APS testing portfolio for IgA, IgG, and IgM.